4//SEC Filing
Arsenault Kaitlyn Melanie 4
Accession 0001516551-21-000027
CIK 0001516551other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:59 PM ET
Size
7.5 KB
Accession
0001516551-21-000027
Insider Transaction Report
Form 4
ARSENAULT KAITLYN
Chief Financial Officer
Transactions
- Award
Common Stock
2021-12-14+1,000,000→ 1,000,000 total - Award
Stock Option (Right to Buy)
2021-12-14+1,770,000→ 1,770,000 totalExercise: $0.06Exp: 2031-12-14→ Common Stock (1,770,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests in three equal annual installments commencing on the first anniversary of the grant date. Upon a change in control of the Issuer, all of the RSUs will vest in full.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The option vests 25% on the one year anniversary of the grant date and 1/48th monthly thereafter. Upon a change in control of the Issuer, 100% of the options will become fully vested.
Documents
Issuer
Skye Bioscience, Inc.
CIK 0001516551
Entity typeother
Related Parties
1- filerCIK 0001877242
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 6:59 PM ET
- Size
- 7.5 KB